Latest Articles

Publication Date
Acute appendicitis due to appendiceal endometriosis: Two case report and literature review.

Appendiceal endometriosis (AE) is a rare condition, with a prevalence ranging from 0.05 % to 1.7 % in patients with endometriosis. It represents <1 % of cases of acute appendicitis …

Published: Dec. 15, 2024, midnight
Clinical characteristics and surgical outcomes of 72 cases of intestinal and urinary tract deep infiltrating endometriosis.

The diagnosis and treatment of intestinal and urinary tract deep infiltrating endometriosis (DIE) remain challenging due to its multiple lesions and nonspecific symptoms and signs. This study retrospectively analyzed 72 …

Published: Dec. 15, 2024, midnight
Queensland public servants to get paid leave for reproductive healthcare - MSN

Queensland public servants to get paid leave for reproductive healthcare MSN

Published: Dec. 14, 2024, 7:51 a.m.
Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks - Frontiers

Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks Frontiers

Published: Dec. 14, 2024, 1:31 a.m.
Social Determinants of Health and Lifestyle Risk Factors Modulate Genetic Susceptibility for Women's Health Outcomes.

Women's health conditions are influenced by both genetic and environmental factors. Understanding these factors individually and their interactions is crucial for implementing preventative, personalized medicine. However, since genetics and environmental …

Published: Dec. 14, 2024, midnight
Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Repare Therapeutics eyes Phase III cancer study after Mythic trial success Yahoo Finance

Published: Dec. 13, 2024, 3:28 p.m.
Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial CRISPR Medicine News

Published: Dec. 13, 2024, 12:56 p.m.
‘Medical Misogyny’ leaves women in years of gynaecological pain: reports - Head Topics

‘Medical Misogyny’ leaves women in years of gynaecological pain: reports Head Topics

Published: Dec. 13, 2024, 11:18 a.m.
Gut Microbiota, Circulating Metabolites and Risk of Endometriosis: A Two-Step Mendelian Randomization Study.

Epidemiological studies and animal models have suggested a possible link between gut microbiota (GM), circulating metabolites, and endometriosis (EMs) pathogenesis. However, whether these associations are causal or merely due to …

Published: Dec. 13, 2024, midnight
Thoracic Endometriosis Syndrome: A Comprehensive Review and Multidisciplinary Approach to Management.

Background: Endometriosis is a systemic, inflammatory, estrogen-dependent condition characterized by endometrial stroma and gland-like lesions outside of the uterus. It causes a range of symptoms, notably chronic pelvic pain, infertility …

Published: Dec. 13, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!